Actelion (XSWX:ATLNE) Accounts Payable : CHF98 Mil (As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Accounts Payable?

Actelion's Accounts Payable for the quarter that ended in Mar. 2017 was CHF98 Mil.

Actelion's quarterly Accounts Payable declined from Sep. 2016 (CHF102 Mil) to Dec. 2016 (CHF83 Mil) but then increased from Dec. 2016 (CHF83 Mil) to Mar. 2017 (CHF98 Mil).

Actelion's annual Accounts Payable increased from Dec. 2014 (CHF74 Mil) to Dec. 2015 (CHF84 Mil) but then declined from Dec. 2015 (CHF84 Mil) to Dec. 2016 (CHF83 Mil).

Actelion Accounts Payable Historical Data

The historical data trend for Actelion's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Accounts Payable Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Accounts Payable

Get a 7-Day Free Trial

90.93

103.61

74.14

83.88

83.01

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Accounts Payable	Get a 7-Day Free Trial															68.01	71.02	101.83	83.01	98.05

Actelion Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Actelion Accounts Payable Related Terms

Thank you for viewing the detailed overview of Actelion's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (XSWX:ATLNE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLNE) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (XSWX:ATLNE) Headlines

No Headlines